AstraZeneca Experiences Approval Delays
AstraZeneca Experiences Approval Delays. The release of asthma drug, Symbicort, is being delayed for approval to young children. Reuters said that regulators have asked Symbicort maker, AstraZeneca Plc, for additional information before it can consider allowing expansion of the drug’s use. Symbicort is an inhaled combination … [Read more...] about AstraZeneca Experiences Approval Delays
Advair Pneumonia Risks for COPD Sufferers
Advair, Symbicort Up Pneumonia Risks. Advair, Symbicort and other inhaled corticosteroids may increase the risk of pneumonia in patients with chronic obstructive pulmonary disease (COPD) by as much as 70%, according to a news study. The study, conducted by researchers at Wake Forest University Baptist Medical Center, was published … [Read more...] about Advair Pneumonia Risks for COPD Sufferers
